Ourania Tsitsilonis

VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals <i>via</i> VEGF receptor Type 2

Apostolos C Ziogas, Nikos G. Gavalas, Marinos Tsiatas et al. · International Journal of Cancer · 2011 · 162 citations

Healthy Individuals, T-regulatory Cell, Immunology +17

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

N. Gavalas, Marinos Tsiatas, Ourania Tsitsilonis et al. · British Journal of Cancer · 2012 · 161 citations · Full text

Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor

Constantin N. Baxevanis, Ioannis F. Voutsas, Ourania Tsitsilonis et al. · The Journal of Immunology · 2000 · 161 citations · Full text

T-regulatory Cell, Immunology, Autologous Tumor +18

Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy

Aristotelis Bamias, Vasiliki Koutsoukou, Evangelos Terpos et al. · Gynecologic Oncology · 2007 · 92 citations

Platinum Resistance, Cancer Immunosurveillance, Malignant Disease +10

Compromised anti-tumor responses in tumor necrosis factor-α knockout mice

Constantin N. Baxevanis, Ioannis F. Voutsas, Ourania Tsitsilonis et al. · European Journal of Immunology · 2000 · 79 citations · Full text

Inflammation, Cancer Immunosurveillance, Autoimmune Disease +14